Form HLTH5811 Pharmacare Special Authority Request - Rivaroxaban for Concomitant Coronary Artery Disease and Peripheral Artery Disease - British Columbia, Canada

The Form HLTH5811 Pharmacare Special Authority Request - Rivaroxaban for Concomitant Coronary Artery Disease and Peripheral Artery Disease in British Columbia, Canada is used to request special authority coverage for the medication Rivaroxaban for patients who have both coronary artery disease and peripheral artery disease. This form is specifically for residents of British Columbia.

The Form HLTH5811 Pharmacare Special Authority Request for Rivaroxaban for Concomitant Coronary Artery Disease and Peripheral Artery Disease in British Columbia, Canada is typically filed by the prescribing healthcare provider or their designated representative.

FAQ

Q: What is the HLTH5811 Pharmacare Special Authority Request?
A: The HLTH5811 Pharmacare Special Authority Request is a form used to request coverage for a specific medication in British Columbia, Canada.

Q: What is Rivaroxaban?
A: Rivaroxaban is a medication used to prevent blood clots.

Q: What is Concomitant Coronary Artery Disease and Peripheral Artery Disease?
A: Concomitant Coronary Artery Disease and Peripheral Artery Disease refers to the presence of both conditions in a patient's body.

Q: Why is Rivaroxaban requested for Concomitant Coronary Artery Disease and Peripheral Artery Disease?
A: Rivaroxaban is requested for Concomitant Coronary Artery Disease and Peripheral Artery Disease to prevent blood clots and reduce the risk of complications.

Q: Who can use the HLTH5811 Pharmacare Special Authority Request form?
A: The HLTH5811 Pharmacare Special Authority Request form can be used by healthcare providers to request coverage for their patients.

Q: Is the HLTH5811 Pharmacare Special Authority Request specific to British Columbia, Canada?
A: Yes, the HLTH5811 Pharmacare Special Authority Request is specific to British Columbia, Canada.

Q: Is Rivaroxaban covered by the Pharmacare program in British Columbia?
A: Coverage for Rivaroxaban can be requested through the Pharmacare program in British Columbia.

Q: What are the eligibility criteria for coverage of Rivaroxaban for Concomitant Coronary Artery Disease and Peripheral Artery Disease?
A: The eligibility criteria for coverage of Rivaroxaban for Concomitant Coronary Artery Disease and Peripheral Artery Disease can be found on the HLTH5811 Pharmacare Special Authority Request form or by contacting the Pharmacare program in British Columbia.